MB, Levis & Associates’s Organon & Co OGN Stock Holding History

MB, Levis & Associates’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.2K	Buy	201 +1	+0.5%	+$8	﹤0.01%	220
2025 Q4	$1.43K	Hold	200	–	–	﹤0.01%	229
2025 Q3	$2.14K	Hold	200	–	–	﹤0.01%	219
2025 Q2	$1.94K	Hold	200	–	–	﹤0.01%	244
2025 Q1	$2.98K	Hold	200	–	–	﹤0.01%	240
2024 Q4	$2.98K	Hold	200	–	–	﹤0.01%	249
2024 Q3	$3.83K	Hold	200	–	–	﹤0.01%	235
2024 Q2	$4.14K	Hold	200	–	–	﹤0.01%	227
2024 Q1	$3.76K	Hold	200	–	–	﹤0.01%	231
2023 Q4	$2.88K	Buy	200 +100	+100%	+$1.36K	﹤0.01%	237
2023 Q3	$1.74K	Hold	100	–	–	﹤0.01%	249
2023 Q2	$2.08K	Hold	100	–	–	﹤0.01%	248
2023 Q1	$2.35K	Hold	100	–	–	﹤0.01%	243
2022 Q4	$2.79K	Buy	+100	New	+$2.56K	﹤0.01%	225

Other funds holding OGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

KBG

Kahn Brothers Group New York $564M AUM 25.3% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PMG

Private Management Group Irvine, California $3.47B AUM 13.39% 1-Year Est. Return

MB, Levis & Associates's OGN Position: Q1 2026 in Review

MB, Levis & Associates increased its Organon & Co (OGN) stake by 0.5% in Q1 2026, buying an estimated $8 and bringing the position to 201 shares worth $1.2K. The position accounts for ﹤0.01% of the portfolio, ranked #220.

MB, Levis & Associates first reported a position in OGN in Q4 2022 and has held it in 14 quarters since. The position peaked at $4.14K in Q2 2024. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

MB, Levis & Associates held 201 shares of Organon & Co worth $1.2K as of Q1 2026.
MB, Levis & Associates bought 1 Organon & Co share in Q1 2026, an estimated $8.
Organon & Co made up ﹤0.01% of MB, Levis & Associates's portfolio in Q1 2026, its #220 holding.
MB, Levis & Associates first reported a position in Organon & Co in Q4 2022 and has held it in 14 quarters since.
MB, Levis & Associates's Organon & Co position peaked at $4.14K in Q2 2024.
603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on MB, Levis & Associates's 13F filing for Q1 2026, filed 8 Apr 2026.